HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Danchin Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2022Oral Condition and Incident Coronary Heart Disease: A Clustering Analysis.
2/2016Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
10/2012Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Danchin Research Topics

Disease

17Myocardial Infarction
06/2020 - 12/2000
13Acute Coronary Syndrome
04/2013 - 11/2001
9Coronary Artery Disease (Coronary Atherosclerosis)
02/2018 - 01/2000
7Hypertension (High Blood Pressure)
01/2022 - 08/2005
7Heart Failure
04/2014 - 01/2002
6Unstable Angina
12/2010 - 05/2000
4Infarction (Infarctions)
06/2020 - 03/2000
4Left Ventricular Dysfunction
06/2007 - 03/2000
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 10/2012
3ST Elevation Myocardial Infarction
06/2020 - 12/2004
3Non-ST Elevated Myocardial Infarction
12/2016 - 12/2000
2Dyslipidemias (Dyslipidemia)
02/2018 - 11/2004
2Hemorrhage
04/2013 - 08/2006
2Ischemia
12/2007 - 12/2000
2Coronary Disease (Coronary Heart Disease)
11/2004 - 07/2001
2Cardiovascular Diseases (Cardiovascular Disease)
06/2003 - 11/2000
2Thrombosis (Thrombus)
06/2003 - 05/2001
2Myocardial Ischemia (Ischemic Heart Diseases)
07/2001 - 12/2000
2Coronary Thrombosis
05/2001 - 11/2000
2Pathologic Constriction (Stenosis)
05/2001 - 11/2000
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Xanthomatosis (Xanthoma)
02/2018
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
02/2018
1Gout
05/2015
1Overweight
04/2011
1Obesity
04/2011
1Ecchymosis
04/2010
1Ventricular Dysfunction
06/2007
1Stable Angina
06/2007
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2006
1Renal Insufficiency (Renal Failure)
09/2005
1Hyperglycemia
08/2005
1Fever (Fevers)
06/2004
1Endocarditis
06/2004
1Pulmonary Hypertension
12/2002
1Hypoxia (Hypoxemia)
12/2002
1Familial Primary Pulmonary Hypertension
12/2002

Drug/Important Bio-Agent (IBA)

5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2014 - 11/2001
3LipidsIBA
01/2022 - 07/2001
3pro-brain natriuretic peptide (1-76)IBA
01/2022 - 01/2004
3CholesterolIBA
01/2022 - 11/2001
3bivalirudin (Angiomax)FDA Link
04/2013 - 12/2007
3Glycoproteins (Glycoprotein)IBA
08/2006 - 11/2001
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2005 - 12/2002
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2003 - 05/2000
2Pharmaceutical PreparationsIBA
01/2022 - 12/2000
2C-Reactive ProteinIBA
06/2020 - 09/2002
2ElementsIBA
02/2018 - 06/2017
2Insulin (Novolin)FDA Link
02/2016 - 10/2012
2Platelet Membrane Glycoprotein IIbIBA
04/2013 - 12/2007
2AnticoagulantsIBA
04/2013 - 08/2006
2omega-Chloroacetophenone (Mace)IBA
10/2011 - 06/2003
2Clopidogrel (Plavix)FDA Link
10/2011 - 06/2003
2Brain Natriuretic Peptide (Natrecor)FDA Link
04/2011 - 01/2004
2LDL CholesterolIBA
02/2011 - 11/2004
2HomocysteineIBA
06/2007 - 01/2000
2CreatinineIBA
01/2007 - 08/2006
2Heparin (Liquaemin)FDA LinkGeneric
08/2006 - 12/2000
2Blood Glucose (Blood Sugar)IBA
07/2006 - 08/2005
2Ticlopidine (Ticlid)FDA LinkGeneric
06/2003 - 05/2000
2Histamine (Histamine Dihydrochloride)FDA Link
01/2002 - 07/2001
2Complement System Proteins (Complement)IBA
01/2002 - 05/2001
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2000 - 11/2000
1HDL LipoproteinsIBA
01/2022
1oxidized low density lipoproteinIBA
01/2022
1Triglycerides (Triacylglycerol)IBA
01/2022
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2022
1PTX3 proteinIBA
06/2020
1Interleukin-6 (Interleukin 6)IBA
06/2020
1Troponin IIBA
06/2020
1LDL Lipoproteins (beta Lipoproteins)IBA
02/2018
1A-factor (Streptomyces)IBA
02/2018
1AntibodiesIBA
12/2016
1ColchicineFDA LinkGeneric
05/2015
1Allopurinol (Remid)FDA LinkGeneric
05/2015
1Xanthine OxidaseIBA
05/2015
1Cytochrome P-450 CYP2C19IBA
10/2011
1Aryldialkylphosphatase (Paraoxonase)IBA
10/2011
1paragonIBA
12/2007
1TroponinIBA
12/2007
1Biomarkers (Surrogate Marker)IBA
06/2007
1DiureticsIBA
01/2007
1Biological ProductsIBA
11/2006
1Coenzyme A (CoA)IBA
08/2006
1Vitamin KFDA Link
09/2005
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2004
1Anti-Bacterial Agents (Antibiotics)IBA
06/2004
1Chewing Gum (Chewing Gums)IBA
06/2004
1thienopyridineIBA
06/2003
1Sildenafil Citrate (Viagra)FDA Link
12/2002
1Iloprost (Ventavis)FDA Link
12/2002
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
12/2002

Therapy/Procedure

11Therapeutics
02/2016 - 12/2000
9Percutaneous Coronary Intervention
06/2020 - 11/2001
5Stents
06/2003 - 03/2000
4Secondary Prevention
11/2014 - 08/2002
1Drug Therapy (Chemotherapy)
04/2014
1Length of Stay
12/2010
1Antibiotic Prophylaxis
06/2004
1Premedication
06/2003